Clinical trial
Biological Therapy and Chemotherapy in Treating Patients With Metastatic Kidney…
NCT00030342 · St. Luke's Medical Center, Other · Completed
Key facts
| NCT number | NCT00030342 |
|---|---|
| Title | Biological Therapy and Chemotherapy in Treating Patients With Metastatic Kidney Cancer or Colorectal Cancer |
| Official title | A Phase I/II Study Of Interleukin-12-Primed Activated T Cells In Combination With 5FU, GM-CSF And Interferon Alfa-2b In Metastatic Renal Cell Carcinoma Or Colorectal Carcinoma |
| Lead sponsor | St. Luke's Medical Center, Other |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Colorectal Cancer, Kidney Cancer |
| Intervention type | Biological, Drug |
| Interventions | recombinant interferon alfa, sargramostim, therapeutic autologous lymphocytes, fluorouracil |
| Enrollment | 60 |
| Start date | Nov 1, 2001 |
| Primary completion | Oct 1, 2007 |
| Completion | Jan 1, 2008 |
| First posted | Jan 27, 2003 |
| Last update posted | Jun 26, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: